Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Feng Lin Road, Shanghai 200032, China.
School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, 826 Zhangheng Road, Shanghai 201203, China.
Biomaterials. 2014 Mar;35(9):2961-70. doi: 10.1016/j.biomaterials.2013.12.038. Epub 2014 Jan 3.
Microthrombosis plays a key role in many cardiovascular diseases. Although it is not difficult to localize thrombus within large or middle-sized vessels, the noninvasive diagnostic regimen for the detection of microthrombus remains scarce. Here we developed a nanoagent by conjucting superparamagnetic iron-oxide nanoparticle with fluorophore and a targeting element, CREKA, a peptide with special affinity for fibrin. In a rat model of myocardial ischemia-reperfusion (MI/R), the multimodal nanoagents were readily and selectively accumulated within microthrombosis, which was detectable by both magnetic resonance and optical imaging modalities. The fibrin-targeted nanoagent could be expected to have utility not only in molecular imaging of fibrin, understanding the mechanisms of microcirculation disorders, but also in targeted therapy with fibrinolytic agents.
微血栓在许多心血管疾病中起着关键作用。虽然在大或中等大小的血管内定位血栓并不困难,但微血栓的无创诊断方案仍然很少。在这里,我们通过将超顺磁氧化铁纳米颗粒与荧光团和靶向元件 CREKA(一种对纤维蛋白具有特殊亲和力的肽)连接起来,开发了一种纳米试剂。在心肌缺血再灌注(MI/R)大鼠模型中,多模式纳米试剂很容易且选择性地积聚在微血栓内,这可通过磁共振和光学成像模式检测到。这种纤维蛋白靶向纳米试剂不仅有望用于纤维蛋白的分子成像、了解微循环障碍的机制,而且还可用于纤维蛋白溶解剂的靶向治疗。